Review



lentiviral dominant negative tcf4 plasmid  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 88

    Structured Review

    Addgene inc lentiviral dominant negative tcf4 plasmid
    Lentiviral Dominant Negative Tcf4 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 88/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dn+tcf4+plasmids/TCF4-DN+in+pLX303+(Plasmid+%2342592)/pm40943659-332-1-12
    Average 88 stars, based on 6 article reviews
    lentiviral dominant negative tcf4 plasmid - by Bioz Stars, 2026-09
    88/100 stars

    Images

    Related Articles

    Dominant Negative Mutation:

    Article Title: Hotspot ESR1 mutations are multimodal and contextual drivers of breast cancer metastasis
    Article Snippet: .. For the dominant negative TCF4 overexpression experiment, Myc-tagged DN TCF4 plasmids (Addgene, #32729) were transiently transfected into targeted cells for a total of 24 hours before being subjected to the wound scratch assay. .. 3,000 MCF7 or 4,000 T47D cells were seeded into 96-well round bottom ultra-low attachment plates (Corning, #7007) with 100μl of respective media in each well.

    Article Title: Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis
    Article Snippet: .. For the dominant negative TCF4 overexpression experiment, Myc-tagged DN TCF4 plasmids (Addgene, #32729) were transiently transfected into targeted cells for a total of 24 hours before being subjected to the wound scratch assay. ..

    Over Expression:

    Article Title: Hotspot ESR1 mutations are multimodal and contextual drivers of breast cancer metastasis
    Article Snippet: .. For the dominant negative TCF4 overexpression experiment, Myc-tagged DN TCF4 plasmids (Addgene, #32729) were transiently transfected into targeted cells for a total of 24 hours before being subjected to the wound scratch assay. .. 3,000 MCF7 or 4,000 T47D cells were seeded into 96-well round bottom ultra-low attachment plates (Corning, #7007) with 100μl of respective media in each well.

    Article Title: Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis
    Article Snippet: .. For the dominant negative TCF4 overexpression experiment, Myc-tagged DN TCF4 plasmids (Addgene, #32729) were transiently transfected into targeted cells for a total of 24 hours before being subjected to the wound scratch assay. ..

    Transfection:

    Article Title: Hotspot ESR1 mutations are multimodal and contextual drivers of breast cancer metastasis
    Article Snippet: .. For the dominant negative TCF4 overexpression experiment, Myc-tagged DN TCF4 plasmids (Addgene, #32729) were transiently transfected into targeted cells for a total of 24 hours before being subjected to the wound scratch assay. .. 3,000 MCF7 or 4,000 T47D cells were seeded into 96-well round bottom ultra-low attachment plates (Corning, #7007) with 100μl of respective media in each well.

    Article Title: Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis
    Article Snippet: .. For the dominant negative TCF4 overexpression experiment, Myc-tagged DN TCF4 plasmids (Addgene, #32729) were transiently transfected into targeted cells for a total of 24 hours before being subjected to the wound scratch assay. ..

    Wound Healing Assay:

    Article Title: Hotspot ESR1 mutations are multimodal and contextual drivers of breast cancer metastasis
    Article Snippet: .. For the dominant negative TCF4 overexpression experiment, Myc-tagged DN TCF4 plasmids (Addgene, #32729) were transiently transfected into targeted cells for a total of 24 hours before being subjected to the wound scratch assay. .. 3,000 MCF7 or 4,000 T47D cells were seeded into 96-well round bottom ultra-low attachment plates (Corning, #7007) with 100μl of respective media in each well.

    Article Title: Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis
    Article Snippet: .. For the dominant negative TCF4 overexpression experiment, Myc-tagged DN TCF4 plasmids (Addgene, #32729) were transiently transfected into targeted cells for a total of 24 hours before being subjected to the wound scratch assay. ..



    Similar Products

    99
    Thermo Fisher dn tcf4 dna plasmids
    Dn Tcf4 Dna Plasmids, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dn+tcf4+plasmids/DNA/pm41421222-77-19-30
    Average 99 stars, based on 1 article reviews
    dn tcf4 dna plasmids - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    88
    Addgene inc lentiviral dominant negative tcf4 plasmid
    Lentiviral Dominant Negative Tcf4 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dn+tcf4+plasmids/TCF4-DN+in+pLX303+(Plasmid+%2342592)/pm40943659-332-1-12
    Average 88 stars, based on 1 article reviews
    lentiviral dominant negative tcf4 plasmid - by Bioz Stars, 2026-09
    88/100 stars
      Buy from Supplier

    88
    Addgene inc tcf4 knockdown plasmid
    <t>TCF4</t> promotes the increased generation of deep-layer neurons. (A) Schematic diagram of TCF4 overexpression clone construction. (B) Western blot validation of TCF4 overexpression clone efficiency. β-actin is as the reference protein. (C-H) pCIG+pCAG (control) and pCIG- Tcf4 +pCAG (TCF4) were electroporated into embryonic brains from mice at E13.5. Brain sections at P3 were immunostained with cortical markers (CUX1 and SOX5). Scale bar: 500 µm (C, D) and 100 µm (E-H, E'-H'). (I) The sections labelled A' to B' were divided into 10 bins to count the distribution of EGFP-positive cells in the cortex. These sections were derived from the electroporated mouse brains, which were from different littermates (control: n=15 sections from 13 brains, TCF4: n=4). (J) Statistical analysis of the percentage of CUX1+/GFP+ cells in (E', F') and SOX5+/GFP+ cells in (G', H') (control: n = 15 sections from 13 brains, TCF4: n=4). Statistical significance was determined using an unpaired two-tailed Student's t-test. *P<0.05, ** P<0.01 and ***P<0.001
    Tcf4 Knockdown Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dn+tcf4+plasmids/TCF4-DN+in+pLX303+(Plasmid+%2342592)/pmc11628341-181-1-10
    Average 88 stars, based on 1 article reviews
    tcf4 knockdown plasmid - by Bioz Stars, 2026-09
    88/100 stars
      Buy from Supplier

    88
    Addgene inc tcf4 dn
    <t>TCF4</t> promotes the increased generation of deep-layer neurons. (A) Schematic diagram of TCF4 overexpression clone construction. (B) Western blot validation of TCF4 overexpression clone efficiency. β-actin is as the reference protein. (C-H) pCIG+pCAG (control) and pCIG- Tcf4 +pCAG (TCF4) were electroporated into embryonic brains from mice at E13.5. Brain sections at P3 were immunostained with cortical markers (CUX1 and SOX5). Scale bar: 500 µm (C, D) and 100 µm (E-H, E'-H'). (I) The sections labelled A' to B' were divided into 10 bins to count the distribution of EGFP-positive cells in the cortex. These sections were derived from the electroporated mouse brains, which were from different littermates (control: n=15 sections from 13 brains, TCF4: n=4). (J) Statistical analysis of the percentage of CUX1+/GFP+ cells in (E', F') and SOX5+/GFP+ cells in (G', H') (control: n = 15 sections from 13 brains, TCF4: n=4). Statistical significance was determined using an unpaired two-tailed Student's t-test. *P<0.05, ** P<0.01 and ***P<0.001
    Tcf4 Dn, supplied by Addgene inc, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dn+tcf4+plasmids/TCF4-DN+in+pLX303+(Plasmid+%2342592)/pmc10565211-188-12-21
    Average 88 stars, based on 1 article reviews
    tcf4 dn - by Bioz Stars, 2026-09
    88/100 stars
      Buy from Supplier

    88
    Addgene inc plx303 plasmid
    <t>TCF4</t> promotes the increased generation of deep-layer neurons. (A) Schematic diagram of TCF4 overexpression clone construction. (B) Western blot validation of TCF4 overexpression clone efficiency. β-actin is as the reference protein. (C-H) pCIG+pCAG (control) and pCIG- Tcf4 +pCAG (TCF4) were electroporated into embryonic brains from mice at E13.5. Brain sections at P3 were immunostained with cortical markers (CUX1 and SOX5). Scale bar: 500 µm (C, D) and 100 µm (E-H, E'-H'). (I) The sections labelled A' to B' were divided into 10 bins to count the distribution of EGFP-positive cells in the cortex. These sections were derived from the electroporated mouse brains, which were from different littermates (control: n=15 sections from 13 brains, TCF4: n=4). (J) Statistical analysis of the percentage of CUX1+/GFP+ cells in (E', F') and SOX5+/GFP+ cells in (G', H') (control: n = 15 sections from 13 brains, TCF4: n=4). Statistical significance was determined using an unpaired two-tailed Student's t-test. *P<0.05, ** P<0.01 and ***P<0.001
    Plx303 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dn+tcf4+plasmids/TCF4-DN+in+pLX303+(Plasmid+%2342592)/pmc10565211-188-14-21
    Average 88 stars, based on 1 article reviews
    plx303 plasmid - by Bioz Stars, 2026-09
    88/100 stars
      Buy from Supplier

    88
    Addgene inc tcf4 gene
    Fig. 8 Reversal of abnormal phenotypes in PTHS organoids after trans-epigenetic correction of <t>TCF4</t> expression. a Schematic representation of CRISPR-based trans-epigenetic correction of TCF4 expression using constructs for guide RNA (gRNA), transcriptional activation module MPH, and dead Cas9 (see “Methods” for details). b Top: Virus application regimen. Bottom: Brightfield images of PTHS brain organoids at 4 weeks in vitro after correction of TCF4 expression (PTHS + TCF4 gRNA), compared with controls transduced with scrambled gRNA (scr gRNA). c Fluorescence microscopy images of transduced organoids at 2 weeks in vitro after immunostaining for TCF4 (green). Clustered TCF4+ cells (arrowhead) can be seen in aberrant outgrowth in image on the right in PTHS + scr gRNA condition. See Supplementary Fig. 12d, e for quantification of number of TCF4+ cells and mean TCF4 staining pixel intensity in transduced organoids. d Increase in TCF4 expression levels after CRISPR-mediated trans-epigenetic TCF4 correction in organoids at 2 weeks in vitro. N = 3 replicates per group (circles). e–g Expression levels of GADD45G (e), CDKN2A (f), and MAP2 (g) in organoids at 4 weeks in vitro after trans- epigenetic TCF4 expression correction. N = 3 replicates per group (circles). Organoids are from parent–patient pair #4. h Transduced organoids stained for MAP2 (magenta) and SOX2 (green), at two developmental time points. Arrowheads in middle panels: polarized PTHS organoids. High mag insets: clustered abnormally shaped MAP2+ cells in polarized organoid outgrowth. Arrowhead in right panel: neural rosettes. Experiments were conducted with organoids from parent-patient pair #4 (circle symbols in bar graphs). Colors in bar graphs represent parents (orange), PTHS (blue), or genetically manipulated PTHS (light blue) groups. Error bars represent SEM. n.s., not significant; *p < 0.05; **p < 0.01; ***p < 0.001; one-way ANOVA followed by Tukey’s HSD post-hoc test in bar plots. Scale bars are 100 μm. DAPI nuclear staining in blue. See Supplementary Data 1 for sample and effect sizes and exact p-values. Attribution of DNA image in a: Ioana Davies/Shutterstock.com.
    Tcf4 Gene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dn+tcf4+plasmids/TCF4-DN+in+pLX303+(Plasmid+%2342592)/pm35501322-739-17-31
    Average 88 stars, based on 1 article reviews
    tcf4 gene - by Bioz Stars, 2026-09
    88/100 stars
      Buy from Supplier

    93
    Addgene inc dn tcf4 plasmids
    Fig. 8 Reversal of abnormal phenotypes in PTHS organoids after trans-epigenetic correction of <t>TCF4</t> expression. a Schematic representation of CRISPR-based trans-epigenetic correction of TCF4 expression using constructs for guide RNA (gRNA), transcriptional activation module MPH, and dead Cas9 (see “Methods” for details). b Top: Virus application regimen. Bottom: Brightfield images of PTHS brain organoids at 4 weeks in vitro after correction of TCF4 expression (PTHS + TCF4 gRNA), compared with controls transduced with scrambled gRNA (scr gRNA). c Fluorescence microscopy images of transduced organoids at 2 weeks in vitro after immunostaining for TCF4 (green). Clustered TCF4+ cells (arrowhead) can be seen in aberrant outgrowth in image on the right in PTHS + scr gRNA condition. See Supplementary Fig. 12d, e for quantification of number of TCF4+ cells and mean TCF4 staining pixel intensity in transduced organoids. d Increase in TCF4 expression levels after CRISPR-mediated trans-epigenetic TCF4 correction in organoids at 2 weeks in vitro. N = 3 replicates per group (circles). e–g Expression levels of GADD45G (e), CDKN2A (f), and MAP2 (g) in organoids at 4 weeks in vitro after trans- epigenetic TCF4 expression correction. N = 3 replicates per group (circles). Organoids are from parent–patient pair #4. h Transduced organoids stained for MAP2 (magenta) and SOX2 (green), at two developmental time points. Arrowheads in middle panels: polarized PTHS organoids. High mag insets: clustered abnormally shaped MAP2+ cells in polarized organoid outgrowth. Arrowhead in right panel: neural rosettes. Experiments were conducted with organoids from parent-patient pair #4 (circle symbols in bar graphs). Colors in bar graphs represent parents (orange), PTHS (blue), or genetically manipulated PTHS (light blue) groups. Error bars represent SEM. n.s., not significant; *p < 0.05; **p < 0.01; ***p < 0.001; one-way ANOVA followed by Tukey’s HSD post-hoc test in bar plots. Scale bars are 100 μm. DAPI nuclear staining in blue. See Supplementary Data 1 for sample and effect sizes and exact p-values. Attribution of DNA image in a: Ioana Davies/Shutterstock.com.
    Dn Tcf4 Plasmids, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dn+tcf4+plasmids/962+human+cyclin+D1+promoter+EtsA+site+mutant+pGL3Basic+(Plasmid+%2332729)/pmc08983597-114-8-11
    Average 93 stars, based on 1 article reviews
    dn tcf4 plasmids - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    TCF4 promotes the increased generation of deep-layer neurons. (A) Schematic diagram of TCF4 overexpression clone construction. (B) Western blot validation of TCF4 overexpression clone efficiency. β-actin is as the reference protein. (C-H) pCIG+pCAG (control) and pCIG- Tcf4 +pCAG (TCF4) were electroporated into embryonic brains from mice at E13.5. Brain sections at P3 were immunostained with cortical markers (CUX1 and SOX5). Scale bar: 500 µm (C, D) and 100 µm (E-H, E'-H'). (I) The sections labelled A' to B' were divided into 10 bins to count the distribution of EGFP-positive cells in the cortex. These sections were derived from the electroporated mouse brains, which were from different littermates (control: n=15 sections from 13 brains, TCF4: n=4). (J) Statistical analysis of the percentage of CUX1+/GFP+ cells in (E', F') and SOX5+/GFP+ cells in (G', H') (control: n = 15 sections from 13 brains, TCF4: n=4). Statistical significance was determined using an unpaired two-tailed Student's t-test. *P<0.05, ** P<0.01 and ***P<0.001

    Journal: International Journal of Biological Sciences

    Article Title: MicroRNA-495 Modulates Neuronal Layer Fate Determination by Targeting Tcf4

    doi: 10.7150/ijbs.94739

    Figure Lengend Snippet: TCF4 promotes the increased generation of deep-layer neurons. (A) Schematic diagram of TCF4 overexpression clone construction. (B) Western blot validation of TCF4 overexpression clone efficiency. β-actin is as the reference protein. (C-H) pCIG+pCAG (control) and pCIG- Tcf4 +pCAG (TCF4) were electroporated into embryonic brains from mice at E13.5. Brain sections at P3 were immunostained with cortical markers (CUX1 and SOX5). Scale bar: 500 µm (C, D) and 100 µm (E-H, E'-H'). (I) The sections labelled A' to B' were divided into 10 bins to count the distribution of EGFP-positive cells in the cortex. These sections were derived from the electroporated mouse brains, which were from different littermates (control: n=15 sections from 13 brains, TCF4: n=4). (J) Statistical analysis of the percentage of CUX1+/GFP+ cells in (E', F') and SOX5+/GFP+ cells in (G', H') (control: n = 15 sections from 13 brains, TCF4: n=4). Statistical significance was determined using an unpaired two-tailed Student's t-test. *P<0.05, ** P<0.01 and ***P<0.001

    Article Snippet: The TCF4 knockdown plasmid was constructed using the pLL3.7 vector (Addgene).

    Techniques: Over Expression, Western Blot, Biomarker Discovery, Control, Derivative Assay, Two Tailed Test

    TCF4 knockdown restrains the generation of deep-layer neurons. (A) Schematic diagram of TCF4 knockdown clone construction. The designations sh1, sh2, and sh3 refer to pLL3.7-sh1- Tcf4 , pLL3.7-sh2- Tcf4 , and pLL3.7-sh3- Tcf4 , respectively. (B) WB validation of TCF4 knockdown clone efficiency. β-actin is as the reference protein. (C-K) pLL3.7-Scr+pCAG, pLL3.7-sh1- Tcf4 + pCAG and pLL3.7-sh2- Tcf4 + pCAG were electroporated into the embryonic brains of mice at E13.5. Brain sections at P3 were immunostained with cortical markers (CUX1 and SOX5). Scale bar: 500 µm (C, D, E) and 100 µm (F-K, F'-K') . (L) The sections labelled F to H were divided into 10 bins to count the distribution of EGFP-positive cells in the cortex. These sections were derived from the electroporated mouse brains, which were from different littermates (Scr: n=3, sh1-Tcf4: n=3, sh2-Tcf4: n=3). (M) The percentage of CUX1+/GFP+ cells and SOX5+/GFP+ cells in (F-K) (Scr: n=3, sh1-Tcf4: n=3, sh2-Tcf4: n=3). Statistical significance was determined using an unpaired two-tailed Student's t-test. Results are expressed as the mean ±SD. P values are shown as *P<0.05, ** P<0.01.

    Journal: International Journal of Biological Sciences

    Article Title: MicroRNA-495 Modulates Neuronal Layer Fate Determination by Targeting Tcf4

    doi: 10.7150/ijbs.94739

    Figure Lengend Snippet: TCF4 knockdown restrains the generation of deep-layer neurons. (A) Schematic diagram of TCF4 knockdown clone construction. The designations sh1, sh2, and sh3 refer to pLL3.7-sh1- Tcf4 , pLL3.7-sh2- Tcf4 , and pLL3.7-sh3- Tcf4 , respectively. (B) WB validation of TCF4 knockdown clone efficiency. β-actin is as the reference protein. (C-K) pLL3.7-Scr+pCAG, pLL3.7-sh1- Tcf4 + pCAG and pLL3.7-sh2- Tcf4 + pCAG were electroporated into the embryonic brains of mice at E13.5. Brain sections at P3 were immunostained with cortical markers (CUX1 and SOX5). Scale bar: 500 µm (C, D, E) and 100 µm (F-K, F'-K') . (L) The sections labelled F to H were divided into 10 bins to count the distribution of EGFP-positive cells in the cortex. These sections were derived from the electroporated mouse brains, which were from different littermates (Scr: n=3, sh1-Tcf4: n=3, sh2-Tcf4: n=3). (M) The percentage of CUX1+/GFP+ cells and SOX5+/GFP+ cells in (F-K) (Scr: n=3, sh1-Tcf4: n=3, sh2-Tcf4: n=3). Statistical significance was determined using an unpaired two-tailed Student's t-test. Results are expressed as the mean ±SD. P values are shown as *P<0.05, ** P<0.01.

    Article Snippet: The TCF4 knockdown plasmid was constructed using the pLL3.7 vector (Addgene).

    Techniques: Knockdown, Biomarker Discovery, Derivative Assay, Two Tailed Test

    Fig. 8 Reversal of abnormal phenotypes in PTHS organoids after trans-epigenetic correction of TCF4 expression. a Schematic representation of CRISPR-based trans-epigenetic correction of TCF4 expression using constructs for guide RNA (gRNA), transcriptional activation module MPH, and dead Cas9 (see “Methods” for details). b Top: Virus application regimen. Bottom: Brightfield images of PTHS brain organoids at 4 weeks in vitro after correction of TCF4 expression (PTHS + TCF4 gRNA), compared with controls transduced with scrambled gRNA (scr gRNA). c Fluorescence microscopy images of transduced organoids at 2 weeks in vitro after immunostaining for TCF4 (green). Clustered TCF4+ cells (arrowhead) can be seen in aberrant outgrowth in image on the right in PTHS + scr gRNA condition. See Supplementary Fig. 12d, e for quantification of number of TCF4+ cells and mean TCF4 staining pixel intensity in transduced organoids. d Increase in TCF4 expression levels after CRISPR-mediated trans-epigenetic TCF4 correction in organoids at 2 weeks in vitro. N = 3 replicates per group (circles). e–g Expression levels of GADD45G (e), CDKN2A (f), and MAP2 (g) in organoids at 4 weeks in vitro after trans- epigenetic TCF4 expression correction. N = 3 replicates per group (circles). Organoids are from parent–patient pair #4. h Transduced organoids stained for MAP2 (magenta) and SOX2 (green), at two developmental time points. Arrowheads in middle panels: polarized PTHS organoids. High mag insets: clustered abnormally shaped MAP2+ cells in polarized organoid outgrowth. Arrowhead in right panel: neural rosettes. Experiments were conducted with organoids from parent-patient pair #4 (circle symbols in bar graphs). Colors in bar graphs represent parents (orange), PTHS (blue), or genetically manipulated PTHS (light blue) groups. Error bars represent SEM. n.s., not significant; *p < 0.05; **p < 0.01; ***p < 0.001; one-way ANOVA followed by Tukey’s HSD post-hoc test in bar plots. Scale bars are 100 μm. DAPI nuclear staining in blue. See Supplementary Data 1 for sample and effect sizes and exact p-values. Attribution of DNA image in a: Ioana Davies/Shutterstock.com.

    Journal: Nature communications

    Article Title: Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron content.

    doi: 10.1038/s41467-022-29942-w

    Figure Lengend Snippet: Fig. 8 Reversal of abnormal phenotypes in PTHS organoids after trans-epigenetic correction of TCF4 expression. a Schematic representation of CRISPR-based trans-epigenetic correction of TCF4 expression using constructs for guide RNA (gRNA), transcriptional activation module MPH, and dead Cas9 (see “Methods” for details). b Top: Virus application regimen. Bottom: Brightfield images of PTHS brain organoids at 4 weeks in vitro after correction of TCF4 expression (PTHS + TCF4 gRNA), compared with controls transduced with scrambled gRNA (scr gRNA). c Fluorescence microscopy images of transduced organoids at 2 weeks in vitro after immunostaining for TCF4 (green). Clustered TCF4+ cells (arrowhead) can be seen in aberrant outgrowth in image on the right in PTHS + scr gRNA condition. See Supplementary Fig. 12d, e for quantification of number of TCF4+ cells and mean TCF4 staining pixel intensity in transduced organoids. d Increase in TCF4 expression levels after CRISPR-mediated trans-epigenetic TCF4 correction in organoids at 2 weeks in vitro. N = 3 replicates per group (circles). e–g Expression levels of GADD45G (e), CDKN2A (f), and MAP2 (g) in organoids at 4 weeks in vitro after trans- epigenetic TCF4 expression correction. N = 3 replicates per group (circles). Organoids are from parent–patient pair #4. h Transduced organoids stained for MAP2 (magenta) and SOX2 (green), at two developmental time points. Arrowheads in middle panels: polarized PTHS organoids. High mag insets: clustered abnormally shaped MAP2+ cells in polarized organoid outgrowth. Arrowhead in right panel: neural rosettes. Experiments were conducted with organoids from parent-patient pair #4 (circle symbols in bar graphs). Colors in bar graphs represent parents (orange), PTHS (blue), or genetically manipulated PTHS (light blue) groups. Error bars represent SEM. n.s., not significant; *p < 0.05; **p < 0.01; ***p < 0.001; one-way ANOVA followed by Tukey’s HSD post-hoc test in bar plots. Scale bars are 100 μm. DAPI nuclear staining in blue. See Supplementary Data 1 for sample and effect sizes and exact p-values. Attribution of DNA image in a: Ioana Davies/Shutterstock.com.

    Article Snippet: To evaluate the efficiency of the designed TCF4 gRNA sequences at increasing the endogenous expression of the TCF4 gene via trans-epigenetic activation, we transfected SH-SY5Y cells with the pLentiSAMv2 and pLentiMPHv2 (Addgene #89308; http://n2t.net/addgene:89308; RRID:Addgene_89308) plasmids, followed by RT-qPCR to verify the levels of TCF4 transcripts.

    Techniques: Expressing, CRISPR, Construct, Activation Assay, Virus, In Vitro, Transduction, Fluorescence, Microscopy, Immunostaining, Staining

    Fig. 10 Model of dysregulated pathways underlying PTHS pathophysiology. Mechanistic model to explain aberrant cellular phenotypes in PTHS neural structures. Due to TCF4 loss-of-function in PTHS, Wnt signaling activity diminishes, in turn leading to decreased SOX3 expression in NPCs, impairing proliferation. Moreover, we observed that SOX4 is also downregulated in PTHS cells, which we suggest impairs neuronal differentiation and content in the PTHS neural tissue.

    Journal: Nature communications

    Article Title: Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron content.

    doi: 10.1038/s41467-022-29942-w

    Figure Lengend Snippet: Fig. 10 Model of dysregulated pathways underlying PTHS pathophysiology. Mechanistic model to explain aberrant cellular phenotypes in PTHS neural structures. Due to TCF4 loss-of-function in PTHS, Wnt signaling activity diminishes, in turn leading to decreased SOX3 expression in NPCs, impairing proliferation. Moreover, we observed that SOX4 is also downregulated in PTHS cells, which we suggest impairs neuronal differentiation and content in the PTHS neural tissue.

    Article Snippet: To evaluate the efficiency of the designed TCF4 gRNA sequences at increasing the endogenous expression of the TCF4 gene via trans-epigenetic activation, we transfected SH-SY5Y cells with the pLentiSAMv2 and pLentiMPHv2 (Addgene #89308; http://n2t.net/addgene:89308; RRID:Addgene_89308) plasmids, followed by RT-qPCR to verify the levels of TCF4 transcripts.

    Techniques: Activity Assay, Expressing